CWAG
ABBV icon

Compton Wealth Advisory Group’s AbbVie ABBV Stock Holding History

Compton Wealth Advisory Group’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$3.74M Sell
14,400
-694
-5% -$178K 0.77% 28
2026
Q2 		$3.79M Sell
15,094
-1
-0% -$215 0.76% 28
2026
Q1 		$3.25M Buy
15,095
+3,256
+28% +$722K 0.72% 30
2025
Q4 		$2.71M Buy
11,839
+70
+0.6% +$15.9K 0.59% 33
2025
Q3 		$2.73M Buy
11,769
+202
+2% +$41.1K 0.63% 33
2025
Q2 		$2.15M Buy
11,567
+119
+1% +$22.1K 0.54% 35
2025
Q1 		$2.4M Buy
11,448
+42
+0.4% +$8.16K 0.67% 31
2024
Q4 		$2.03M Sell
11,406
-221
-2% -$40.6K 0.52% 40
2024
Q3 		$2.3M Sell
11,627
-83
-0.7% -$15.5K 0.58% 37
2024
Q2 		$2.01M Buy
11,710
+452
+4% +$74.9K 0.54% 40
2024
Q1 		$2.05M Buy
11,258
+102
+0.9% +$17.6K 0.56% 40
2023
Q4 		$1.73M Buy
11,156
+1,155
+12% +$168K 0.54% 40
2023
Q3 		$1.49M Buy
10,001
+65
+0.7% +$9.5K 0.51% 37
2023
Q2 		$1.34M Sell
9,936
-179
-2% -$26.2K 0.45% 41
2023
Q1 		$1.61M Buy
10,115
+5,982
+145% +$915K 0.56% 38
2022
Q4 		$668K Buy
4,133
+100
+2% +$15.3K 0.26% 61
2022
Q3 		$541K Sell
4,033
-84
-2% -$12.1K 0.23% 64
2022
Q2 		$630K Buy
4,117
+260
+7% +$39.7K 0.27% 65
2022
Q1 		$625K Buy
3,857
+1,255
+48% +$182K 0.24% 71
2021
Q4 		$352K Sell
2,602
-172
-6% -$20.3K 0.15% 68
2021
Q3 		$299K Buy
2,774
+18
+0.7% +$2.06K 0.14% 67
2021
Q2 		$310K Buy
2,756
+18
+0.7% +$2.03K 0.14% 66
2021
Q1 		$296K Buy
2,738
+27
+1% +$2.89K 0.17% 68
2020
Q4 		$290K Sell
2,711
-357
-12% -$34.3K 0.18% 64
2020
Q3 		$269K Buy
3,068
+409
+15% +$38.5K 0.2% 60
2020
Q2 		$261K Buy
2,659
+27
+1% +$2.38K 0.28% 58
2020
Q1 		$200K Buy
2,632
+200
+8% +$17K 0.26% 52
2019
Q4 		$215K Sell
2,432
-10,740
-82% -$892K 0.19% 54
2019
Q3 		$997K Sell
13,172
-786
-6% -$53.9K 0.55% 37
2019
Q2 		$1.02M Hold
13,958
– – 0.52% 34
2019
Q1 		$1.12M Hold
13,958
– – 0.6% 32
2018
Q4 		$1.29M Buy
+13,958
New +$1.23M 0.66% 23

Other funds holding ABBV

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
Hamlin Capital Management
Hamlin Capital Management New York $4.04B AUM 11.59% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return
Ferguson Wellman Capital Management
Ferguson Wellman Capital Management Portland, Oregon $8.38B AUM 25.07% 1-Year Est. Return
MN Services Vermogensbeheer
MN Services Vermogensbeheer The Hague, Netherlands $13.4B AUM 37.34% 1-Year Est. Return
Fjarde Ap-fonden
Fjarde Ap-fonden Stockholm, Sweden $19.4B AUM 31.69% 1-Year Est. Return
Czech National Bank
Czech National Bank Prague, Czech Republic $18.9B AUM 36.24% 1-Year Est. Return
Artemis Investment Management
Artemis Investment Management Edinburgh, United Kingdom $11.5B AUM 61.77% 1-Year Est. Return
IFM Investors
IFM Investors Melbourne, Australia $16B AUM 33.69% 1-Year Est. Return
Vontobel Holding
Vontobel Holding Zurich, Switzerland $27.7B AUM 21.75% 1-Year Est. Return

Compton Wealth Advisory Group's ABBV Position: Q3 2026 in Review

Compton Wealth Advisory Group reduced its AbbVie (ABBV) stake by 4.6% in Q3 2026, selling an estimated $178K and leaving 14,400 shares worth $3.74M. The position accounts for 0.77% of the portfolio, ranked #28.

Compton Wealth Advisory Group first reported a position in ABBV in Q4 2018 and has held it in 32 quarters since. The position peaked at $3.79M in Q2 2026. 921 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.

  • Compton Wealth Advisory Group held 14,400 shares of AbbVie worth $3.74M as of Q3 2026.
  • Compton Wealth Advisory Group sold 694 AbbVie shares in Q3 2026, an estimated $178K.
  • AbbVie made up 0.77% of Compton Wealth Advisory Group's portfolio in Q3 2026, its #28 holding.
  • Compton Wealth Advisory Group first reported a position in AbbVie in Q4 2018 and has held it in 32 quarters since.
  • Compton Wealth Advisory Group's AbbVie position peaked at $3.79M in Q2 2026.
  • 921 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.

Based on Compton Wealth Advisory Group's 13F filing for Q3 2026, filed 13 Oct 2026.